DRKS00031066RecruitingNot Applicable
Influencing factors on weight gain under mirtazapine? A restrospective analyses of routine data
VR-Klinik Düsseldorf0 sites2,000 target enrollmentStarted: January 18, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 2,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •patients, which were treated newly with mirtazapin for more than 28 days
Exclusion Criteria
- •patients, which were already treated with mirtazapine
Investigators
Similar Trials
Completed
Not Applicable
Effect of Topiramate on body weight of patients with schizophrenia treated with OlanzapineSchizophrenia.SchizophreniaIRCT201402085280N15Mashhad University of Medical Sciences48
Completed
Phase 4
Weight Gain Management in Patients With SchizophreniaSchizophreniaNCT00486005Eli Lilly and Company74
Completed
Not Applicable
Weight gain and appetite changes following treatment for thyrotoxicosis – a pilot studyThyrotoxicosisACTRN12616000843459Waikato Hospital20
Completed
Not Applicable
Mirtazapine in Alzheimer-associated Weight LossAlzheimer's DiseaseWeight LossMixed DementiaDementiaNCT01505504Brugmann University Hospital22
Completed
Not Applicable
Mirtazapine augmentation enhances cognitive and negative symptoms in schizophrenic patients treated with risperidone: a randomised controlled trialSchizophreniaISRCTN54975957Bundang CHA Hospital (South Korea)25